Sign in

CIK 0000711377 · Large accelerated filer

NEOGEN CORP

Sign in to watch
Ticker
NEOG
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
May 31
Incorporated
MI
Entity type
operating
EIN
382367843
Phone
5173729200
Business address
620 LESHER PLACE, LANSING, MI, 48912
Open-market buys, last 90 days
$6,035
in 1 filing
Open-market sales, last 90 days
$114,676
in 1 filing

Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Yarwood Jeremy −$115K Chief Scientific Officer sold 100% of stake
  2. Nassif Mikheal +$6K CEO 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-04-28 Jones Douglas Edward Chief Operating Officer Shares withheld for taxes −291 $5.16 $2K 71,713
2025-04-28 Jones Douglas Edward Chief Operating Officer Option exercise · Restricted Stock Units −845 $5.16 $4K 1,690
2025-04-28 Rocklin Amy M Chief Legal Officer Option exercise +564 $5.16 $3K 36,851
2025-04-28 Rocklin Amy M Chief Legal Officer Option exercise · Restricted Stock Units −564 $5.16 $3K 1,128
2025-04-25 Woteki Catherine E Director Purchase +5,770 $5.17 $30K 13,244
2025-04-24 BOREL JAMES C Director Purchase +30,000 $4.99 $150K 90,474
2025-04-24 BOEHM WILLIAM T Director Purchase +5,000 $5.24 $26K 36,214
2025-04-24 BOREL JAMES C Director Purchase +35,000 $4.89 $171K 60,474
2025-04-23 Rocklin Amy M Chief Legal Officer Purchase +12,500 $4.99 $62K 36,287
2025-04-22 CAPELLO JEFFREY D Director Purchase +20,712 $4.84 $100K 26,629

Page 11 of 11 · 210 trades